Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.69 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | CA4 | P22748 | 5/20 | 0.50 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 2/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.38 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.38 |
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL15005641 | 0.96 | CA1 (0.64) | CA1LMNACA4FAHD1CA5A | |
| Phosphoric Acid SCHEMBL2362457 | 0.96 | CA1 (0.64) | CA1LMNACA4FAHD1CA5A | |
| Phosphoric Acid SCHEMBL31536919 | 0.96 | CA1 (0.64) | CA1LMNACA4FAHD1CA5A | |
| Phosphoric Acid SCHEMBL2362456 | 0.96 | CA1 (0.64) | CA1LMNACA4FAHD1CA5A | |
| Phosphoric Acid SCHEMBL6844517 | 0.92 | CA1 (0.61) | CA1LMNACA4FAHD1SLC34A1 | |
| Phosphoric Acid SCHEMBL17978034 | 0.92 | CA1 (0.61) | CA1LMNACA4CA5ACA5B | |
| Phosphoric Acid SCHEMBL10839221 | 0.92 | CA1 (0.61) | CA1LMNACA4CA5ACA5B | |
| Phosphoric Acid SCHEMBL10838736 | 0.92 | CA1 (0.61) | CA1LMNACA4CA5ACA5B | |
| Phosphoric Acid SCHEMBL31657790 | 0.92 | CA1 (0.61) | CA1LMNACA4CA5ACA5B | |
| Phosphoric Acid SCHEMBL5313169 | 0.89 | CA1 (0.64) | CA1LMNACA4FAHD1CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8802416-B2 | Thermostable organic solvent tolerant protease from gram-positive bacteria | UNIVERSITI PUTRA MALAYSIA (MY) | 2014-08-12 | — | — | US | claimed |
| US-20110097784-A1 | THERMOSTABLE ORGANIC SOLVENT TOLERANT PROTEASE FROM GRAM-POSITIVE BACTERIA | UNIVERSITI PUTRA MALAYSIA | 2011-04-28 | — | — | US | claimed |
| CN-118213508-A | Silicon-carbon composite material, negative plate and battery | 珠海冠宇电池股份有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-117881402-A | Nucleotide and nucleoside therapeutic compositions, combinations, and uses related thereto | 埃默里大学 | 2024-04-12 | — | — | CN | disclosed |
| EP-4021453-A1 | COMPOUNDS TO IDENTIFY BETA-LACTAMASES, AND METHODS OF USE THEREOF | The Regents of The University of California (US) | 2022-07-06 | — | — | EP | disclosed |
| US-20220177947-A1 | Compounds to Identify Beta-Lactamases, and Methods of Use Thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-06-09 | — | — | US | disclosed |
| WO-2021041583-A1 | COMPOUNDS TO IDENTIFY BETA-LACTAMASES, AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-03-04 | — | — | WO | disclosed |
| EP-2270044-B1 | Liquid immunoglobulin G (lgG) product | CSL BEHRING AG (CH) | 2014-11-05 | — | — | EP | disclosed |
| US-8802416-B2 | Thermostable organic solvent tolerant protease from gram-positive bacteria | UNIVERSITI PUTRA MALAYSIA (MY) | 2014-08-12 | — | — | US | disclosed |
| EP-2272870-B1 | Process for manufacturing immunoglobulins for intravenous administration and other immunoglobulin-like products | CSL BEHRING AG (CH) | 2013-05-08 | — | — | EP | disclosed |
| US-20110097784-A1 | THERMOSTABLE ORGANIC SOLVENT TOLERANT PROTEASE FROM GRAM-POSITIVE BACTERIA | UNIVERSITI PUTRA MALAYSIA | 2011-04-28 | — | — | US | disclosed |
| EP-2272870-A1 | Process for manufacturing immunoglobulins for intravenous administration and other immunoglobulin-like products | CSL Behring AG (CH) | 2011-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220177947-A1 | Compounds to Identify Beta-Lactamases, and Methods of Use Thereof | GUSB, GLB1, MGAM | CA1 3333/4885LMNA 403/4885CA4 1421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.